Ionis Pharmaceuticals IONS Number of operating segments
Number of operating segments at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NumberOfOperatingSegments.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's number of operating segments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's number of operating segments?
- Ionis Pharmaceuticals (IONS) reported number of operating segments of 1 in Q1 2026.
- How has Ionis Pharmaceuticals's number of operating segments changed year-over-year?
- Ionis Pharmaceuticals's number of operating segments increased by 300.0% year-over-year, from 0.3 to 1.
- What does number of operating segments mean?
- The total number of distinct business units that management tracks and evaluates separately.
- How do you interpret number of operating segments?
- An increase suggests business diversification or a more complex organizational structure, while a decrease may indicate consolidation or a focus on core competencies.
- How does number of operating segments compare across companies?
- Biotech companies often report based on therapeutic focus or development stage, and peers typically maintain a low number of segments to reflect a focused R&D strategy.